FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for LUMIGAN (bimatoprost).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

SUPPL AP for LUMIGAN (BIMATOPROST)